St. Jude Medical recently announced that patient enrollment has begun in the
Atrial Fibrillation Suppression Pacing in Cardiac Resynchronization Therapy
Devices (CRT-D) clinical study. The study evaluates the Company's proprietary
AF Suppression algorithm, clinically proven to suppress episodes of atrial fibrillation
(AF), and how it impacts the effectiveness of cardiac resynchronization therapy
in heart failure patients.
St. Jude Medical